Cosciens Biopharma Inc.TSX: CSCI

Aeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warrants

· Issued by Cosciens Biopharma Inc.

Philip Theodore, Senior Vice President, ptheodore@aezsinc.comCopyright CNW Group 2015